InMode (INMD) Non-Current Deferred Tax Liability (2018 - 2019)
InMode's (INMD) quarterly Non-Current Deferred Tax Liability came in at $37000.0 in Q4 2019, up 236.36% year-over-year from $11000.0 in Q4 2018, and down 21.28% quarter-over-quarter from $47000.0 in Q3 2019.
Powered by 
Analysis
InMode (INMD) Non-Current Deferred Tax Liability (2018 - 2019) Analysis & Trends
InMode has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $37000.0 for Q4 2019.
- In Q4 2019, Non-Current Deferred Tax Liability rose 236.36% year-over-year to $37000.0; the TTM figure through Dec 2019 stood at $37000.0 (up 236.36% YoY), while the FY2019 annual figure was $37000.0, up 236.36% from the prior year.
- Non-Current Deferred Tax Liability came in at $37000.0 for Q4 2019 at InMode, down from $47000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $57000.0 in Q2 2019 to a low of $11000.0 in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | InMode | 955.60 Mn | 473.48 Mn | 71.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 37,000.00 |
| Sep 30, 2019 | 47,000.00 |
| Jun 30, 2019 | 57,000.00 |
| Dec 31, 2018 | 11,000.00 |